Oramed Pharma
(ORMP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 08-2021 | |
| Sales | 0 | 1,340 | 2,703 | 904 | 2,703 |
| Gross Profit | N/A | 1,340 | 2,703 | 904 | 2,703 |
| Operating Expenses | 12,781 | 17,109 | 43,301 | 13,230 | 26,926 |
| Operating Income | -12,781 | -15,769 | -40,598 | -12,326 | -24,223 |
| Interest Expense | 853 | 2,037 | 0 | 87 | 8 |
| Other Income | -2,286 | 22,894 | 2,934 | 158 | 1,242 |
| Pre-tax Income | -15,920 | 5,088 | -37,664 | -12,255 | -22,989 |
| Income Tax | 3,183 | N/A | 100 | N/A | N/A |
| Net Income Continuous | -19,103 | 5,088 | -37,764 | -12,255 | -22,989 |
| Minority Interests | -43 | -437 | -1,203 | -587 | -751 |
| Net Income | $-19,060 | $5,525 | $-36,561 | $-11,668 | $-22,238 |
| EPS Basic Total Ops | -0.48 | 0.14 | -0.94 | -0.31 | -0.78 |
| EPS Basic Continuous Ops | -0.47 | 0.13 | -0.97 | -0.33 | -0.81 |
| EPS Diluted Total Ops | -0.48 | 0.14 | -0.94 | -0.31 | -0.78 |
| EPS Diluted Continuous Ops | -0.47 | 0.13 | -0.97 | -0.33 | -0.81 |
| EPS Diluted Before Non-Recurring Items | -0.48 | -0.27 | -0.94 | -0.78 | N/A |
| EBITDA(a) | $-12,588 | $-15,573 | $-40,540 | $-12,308 | $-24,146 |